The professor discussed the results of his clinical trial that evaluated the effectiveness of “Therabot,” an artificial intelligence psychotherapy chatbot.

In today's digital age, the concept of artificial intelligence (AI) stepping into the therapist's chair isn't just science ...

A big reason for the gap is that ordinary Americans are far less optimistic about the effect that AI will have on important ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

Ben Zhao, Professor University of Chicago and his team of researchers built Nightshade and Glaze to push back against the ...

The study was published in March in the journal NEJM AI. Researchers conducted a trial with 106 people who used Therabot, a ...

Axsome Therapeutics said it's dopamine and norepinephrine reuptake inhibitor solriamfetol (Sunosi), approved for excessive daytime sleepiness, failed to reduce symptoms of major depressive disorder in ...

A generative AI–powered therapy chatbot is linked to significant reductions in symptoms of depression, anxiety, and eating ...

A clinical trial conducted by  Dartmouth researchers has shown the potential of a generative AI-powered therapy chatbot ...

Dartmouth’s AI chatbot Therabot cut depression symptoms by 51% in a trial, showing promise as a scalable mental health tool ...

The evidence-backed model delivered impressive results, but it doesn’t validate the wave of AI therapy bots flooding the ...

The first clinical trial of a generative AI therapy bot suggests it was as effective as human therapy for people with ...